Atara Biotherapeutics director granted 12,000 RSUs
Ciongoli Gregory Austin reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Ciongoli Gregory Austin reported acquisition or exercise transactions in this Form 4 filing.
Atara Biotherapeutics director Gregory A. Ciongoli reported an equity compensation award and updated his indirect holdings. He received a grant of 12,000 shares of common stock as a restricted stock unit award at a price of $0.00 per share.
These restricted stock units vest on the earlier of June 9, 2027 or the date of the next annual meeting of stockholders, subject to his continuous service. The filing also reports 1,209,395 shares of common stock indirectly held by Adiumentum Capital Fund I LP, a Delaware limited partnership with which Ciongoli and its general partner are associated, while all parties disclaim beneficial ownership except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 12,000 shares
Grant/Award
2 txns
Insider
Ciongoli Gregory Austin
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 12,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 12,000 shares (Direct);
Common Stock — 1,209,395 shares (Indirect, See Footnote)
Footnotes (2)
- F1. These restricted stock units shall vest on the earlier of June 9, 2027 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
- F2. The securities reported on this row are directly held by Adiumentum Capital Fund I LP, a limited partnership organized under the laws of Delaware ("Adiumentum"). Adiumentum Capital Fund I GP LLC, a limited liability company organized under the laws of Delaware ("Adiumentum GP"), is the general partner of Adiumentum. Gregory A. Ciongoli is the managing partner of Adiumentum and the managing member of Adiumentum GP. Each of Adiumentum, Adiumentum GP, and Mr. Ciongoli may be deemed to have the shared power to vote or direct the vote (and the shared power to dispose or direct the disposition of) the securities that are directly held by Adiumentum. Each of Adiumentum, Adiumentum GP, and Mr. Ciongoli may be deemed to have a pecuniary interest in the securities that are directly held by Adiumentum, but disclaims any beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
Key Figures
RSU grant: 12,000 shares
Grant price: $0.00 per share
RSU vesting date: June 9, 2027
+1 more
4 metrics
RSU grant
12,000 shares
Restricted stock unit award of common stock
Grant price
$0.00 per share
Price per share for 12,000-share RSU grant
RSU vesting date
June 9, 2027
Vests on earlier of June 9, 2027 or next annual meeting
Indirect holdings
1,209,395 shares
Common stock held by Adiumentum Capital Fund I LP
Key Terms
restricted stock units, continuous service, limited partnership, beneficial ownership, +1 more
5 terms
restricted stock units financial
"These restricted stock units shall vest on the earlier of June 9, 2027 or the date of the next annual meeting of stockholders"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
continuous service financial
"subject to the Reporting Person's continuous service"
limited partnership financial
"Adiumentum Capital Fund I LP, a limited partnership organized under the laws of Delaware"
A limited partnership is a legal business structure with two types of partners: at least one general partner who runs the business and bears full legal responsibility, and one or more limited partners who contribute money, share profits, and have liability capped at their investment. For investors, it matters because it separates control from financial exposure — like putting money into a store without managing it — and affects how returns, risks, taxes and transferability of ownership are handled.
beneficial ownership financial
"disclaims any beneficial ownership of such securities, except to the extent of any pecuniary interest therein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"may be deemed to have a pecuniary interest in the securities that are directly held by Adiumentum"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Atara Biotherapeutics (ATRA) disclose in Gregory Ciongoli’s latest Form 4?
Atara Biotherapeutics disclosed that director and 10% owner Gregory A. Ciongoli received a grant of 12,000 restricted stock units and reported indirect holdings of 1,209,395 common shares through Adiumentum Capital Fund I LP, a Delaware limited partnership.
When do Gregory Ciongoli’s 12,000 Atara restricted stock units vest?
The 12,000 restricted stock units granted to Gregory A. Ciongoli vest on the earlier of June 9, 2027 or the date of Atara Biotherapeutics’ next annual meeting of stockholders, provided he maintains continuous service with the company through the applicable vesting date.
What indirect Atara Biotherapeutics holdings are associated with Adiumentum Capital Fund I LP?
The filing reports 1,209,395 shares of Atara Biotherapeutics common stock indirectly held by Adiumentum Capital Fund I LP. Adiumentum, its general partner, and Gregory A. Ciongoli may share voting and dispositive power, while each disclaims beneficial ownership except for any pecuniary interest.
Is Gregory Ciongoli considered a 10% owner of Atara Biotherapeutics?
Yes. The Form 4 identifies Gregory A. Ciongoli as both a director and a 10% owner of Atara Biotherapeutics. His reported holdings include a 12,000-share restricted stock unit award and indirect interests in 1,209,395 common shares held by Adiumentum Capital Fund I LP.
AI-generated analysis. How Rhea-AI works. Not financial advice.
